Search results
Eli Lilly Raised Its Outlook. Is the Stock a Buy Now?
Motley Fool via Yahoo Finance· 23 hours agoEli Lilly (NYSE: LLY) stock has been a top performer thanks to runaway sales of its...
Eli Lilly and Company (NYSE:LLY) Price Target Raised to $1,001.00
ETF DAILY NEWS· 1 day agoEli Lilly and Company (NYSE:LLY – Free Report) had its price target hoisted by BMO Capital Markets from $900.00 to $1,001.00 in a report released on Wednesday ...
Eli Lilly shares target raised by BMO Capital on recent earnings miss By Investing.com
Investing.com· 4 days agoOn Tuesday, BMO Capital Markets adjusted its outlook on Eli Lilly and Company (NYSE:LLY), raising...
Truist Financial Raises Eli Lilly and Company (NYSE:LLY) Price Target to $892.00
ETF DAILY NEWS· 1 day agoEli Lilly and Company (NYSE:LLY – Free Report) had its price target boosted by Truist Financial from $850.00 to $892.00 in a report released on Wednesday ...
Move Over, Mounjaro. Eli Lilly Has Another Blockbuster in the Making
Motley Fool via Yahoo Finance· 20 hours agoPerhaps the most well-known GLP-1 drugs are diabetes medication Ozempic and obesity care treatment...
Eli Lilly earnings beat by $0.10, revenue fell short of estimates By Investing.com
Investing.com· 5 days agoEli Lilly earnings beat by $0.10, revenue fell short of estimates
Analysts reveal Eli Lilly stock price targets after earnings
TheStreet via Yahoo Finance· 2 days agoThe people at Eli Lilly (LLY) say they're working as fast as they can. The drugmaker, which reported...
Eli Lilly and Company (NYSE:LLY) Just Released Its First-Quarter Earnings: Here's What Analysts...
Simply Wall St. via Yahoo Finance· 3 days agoIt's been a good week for Eli Lilly and Company (NYSE:LLY) shareholders, because the company has...
Eli Lilly stock climbs on gross margin beat, raised 2024 revenue outlook By Investing.com
Investing.com· 5 days agoEli Lilly & Co. (NYSE:LLY) saw its shares jump 5.4% in premarket trading Tuesday after the...
Eli Lilly assures investors it can overcome the high-quality problem of too much demand
CNBC· 5 days agoEli Lilly 's raised guidance stole the show Tuesday, offsetting mixed first-quarter results and propelling shares higher by nearly 6%. The numbers leave ...